Cullen Frost Bankers Inc. Has $256,000 Position in Humana Inc. (NYSE:HUM)

Cullen Frost Bankers Inc. decreased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 95.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,011 shares of the insurance provider's stock after selling 23,827 shares during the quarter. Cullen Frost Bankers Inc.'s holdings in Humana were worth $256,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of HUM. Transcend Capital Advisors LLC lifted its holdings in Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after acquiring an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC grew its position in Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after buying an additional 26,856 shares during the last quarter. Retirement Systems of Alabama increased its holdings in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after buying an additional 65,735 shares in the last quarter. Finally, PDT Partners LLC lifted its position in shares of Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after acquiring an additional 2,660 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on HUM shares. StockNews.com lowered Humana from a "buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial lifted their target price on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. JPMorgan Chase & Co. cut their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Finally, Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Twenty research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Humana has an average rating of "Hold" and a consensus price target of $285.68.

Humana Stock Performance

HUM traded down $0.88 on Wednesday, hitting $249.32. The company had a trading volume of 920,822 shares, compared to its average volume of 1,658,084. The stock has a market cap of $30.08 billion, a price-to-earnings ratio of 25.06, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company's fifty day moving average price is $271.67 and its 200 day moving average price is $281.65. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.42%. Humana's dividend payout ratio is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.